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Abstract: International challenges have become the standard for validation of biomedical image 
analysis methods. Given their scientific impact, it is surprising that a critical analysis of common 
practices related to the organization of challenges has not yet been performed. In this paper, we 
present a comprehensive analysis of biomedical image analysis challenges conducted up to now. 
We demonstrate the importance of challenges and show that the lack of quality control has critical 
consequences. First, reproducibility and interpretation of the results is often hampered as only a 
fraction of relevant information is typically provided. Second, the rank of an algorithm is generally 
not robust to a number of variables such as the test data used for validation, the ranking scheme 
applied and the observers that make the reference annotations. To overcome these problems, we 
recommend best practice guidelines and define open research questions to be addressed in the 
future. 
 
1. Introduction 
Biomedical image analysis has become a major research field in biomedical research, with 
thousands of papers published on various image analysis topics including segmentation, 
registration, visualization, quantification, object tracking and detection [Ayache and Duncan 2016, 
Chen et al. 2017]. For a long time, validation and evaluation of new methods were based on the 
authors’ personal data sets, rendering fair and direct comparison of the solutions impossible [Price 
1986]. The first known efforts to address this problem date back to the late 90s [West et al. 1997], 
when Jay West, J Michael Fitzpatrick and colleagues performed an international comparative 
evaluation on intermodality brain image registration techniques. To ensure a fair comparison of the 
algorithms, the participants of the study had no knowledge of the gold standard results until after 
their results had been submitted. A few years later, the ImageCLEF1 [Müller et al. 2004] evaluation 
campaign introduced a challenge on medical image retrieval [Kalpathy-Cramer et al. 2015], based 
on experiences in the text retrieval domain where systematic evaluation had been performed since 
the 1960s [Cleverdon 1960]. About one decade ago, a broader interest in biomedical challenge 
organization arose with the first grand challenge that was organized in the scope of the 
international conference on Medical Image Computing and Computer Assisted Intervention 
(MICCAI) 2007 [Heimann et al. 2009]. Over time, research practice began to change, and the 
number of challenges organized annually has been increasing steadily (Fig. 1a)), with currently 
about 28 biomedical image analysis challenges with a mean of 4 tasks conducted annually. Today, 
biomedical image analysis challenges are often published in prestigious journals (e.g. [Chenouard 
et al. 2014, Sage et al. 2015, Menze et al. 2015, Ulman et al. 2017, Maier-Hein et al. 2017]) and 
receive a huge amount of attention with hundreds of citations and thousands of views. Awarding 
the winner with a significant amount of prize money (up to €1 million on platforms like Kaggle 
[kaggle]) is also becoming increasingly common. 
This development was a great step forward, yet the increasing scientific impact [Tassey et al. 
2010, Tsikrika, Herrera and Müller 2011] of challenges now puts huge responsibility on the 
shoulders of the challenge hosts that take care of the organization and design of such 
competitions. The performance of an algorithm on challenge data is essential, not only for the 
acceptance of a paper and its impact on the community, but also for the individuals’ scientific 
careers, and the potential that algorithms can be translated into clinical practice. Given that this is 
so important, it is surprising that no commonly respected quality control processes for biomedical 
challenge design exist to date. Similar problems exist in other research communities, such as 
computer vision and machine learning. 
In this paper, we present the first comprehensive evaluation of biomedical image analysis 
challenges based on 150 challenges conducted up until the end of 2016. It demonstrates the 
                                               
1 http://www.imageclef.org/ 
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crucial nature of challenges for the field of biomedical image analysis, but also reveals major 
problems to be addressed: Reproduction, adequate interpretation and cross-comparison of results 
are not possible in the majority of challenges, as only a fraction of the relevant information is 
reported and challenge design (e.g. a choice of metrics and methods for rank computation) is 
highly heterogeneous. Furthermore, the rank of an algorithm in a challenge is sensitive to a 
number of design choices, including the test data sets used for validation, the observer(s) who 
annotated the data and the metrics chosen for performance assessment, as well as the methods 
used for aggregating values. 
 
2. Results 
150 biomedical image analysis challenges 
Up until the end of 2016, 150 biomedical image analysis challenges that met our inclusion criteria 
(see Online Methods) were conducted with a total of 549 different image analysis tasks (see 
Fig. 1). 56% of these challenges published their results in journals or conference proceedings. The 
information used in this paper from the remaining challenges was acquired from websites. Most 
tasks were related to segmentation (70%) and classification (10%) and were organized within the 
context of the MICCAI conference (50%), and the IEEE International Symposium on Biomedical 
Imaging (ISBI) (following at 34%). The majority of the tasks dealt with 3D (including 3D+t) data 
(84%), and the most commonly applied imaging techniques were magnetic resonance imaging 
(MRI) (62%), computed tomography (CT) (40%) and microscopy (12%). The percentage of tasks 
that used in vivo, in silico, ex vivo, in vitro, post mortem and phantom data was 85%, 4%, 3%, 2%, 
2% and 1%, respectively (9%: N/A; 3%: combination of multiple types). The in vivo data was 
acquired from patients in clinical routine (60%), from patients under controlled conditions (9%), 
from animals (8%), from healthy human subjects (5%), or from humans under unknown (i.e. not 
reported) conditions (32%). While training data is typically provided by the challenge organizers 
(85% of all tasks), the number of training cases varies significantly across the tasks (median: 15; 
interquartile range (IQR): (7, 30); min: 1, max: 32,468). As with the training cases, the number of 
test cases varies across the tasks (median: 20; IQR: (12, 33); min: 1, max: 30,804). The median 
ratio of training cases to test cases was 0.75. The test data used differs considerably from the 
training data, not only in quantity but also in quality. For 73% of all tasks with human or hybrid 
reference generation, multiple observers have annotated the reference data. In these cases, an 
image was annotated by a median of 3 (IQR: (3, 4), max: 9) observers. 
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Fig. 1: Overview of biomedical image analysis challenges. (a) Number of competitions (challenges 
and tasks) organized per year, (b) fields of application, (c) algorithm categories assessed in the 
challenges, (d) imaging techniques applied, (e) number of training and test cases used, (f) most 
commonly applied metrics for performance assessment used in at least 5 tasks and (g) platforms 
(e.g. conferences) used to organize the challenges for the years 2008, 2012 and 2016. 
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Half of the relevant information is not reported 
We identified the relevant parameters that characterize a biomedical challenge following an 
ontological approach (see Online Methods). This yielded a total of 53 parameters corresponding to 
the categories challenge organization, participation conditions, validation objective, study 
conditions, validation data sets, assessment method and challenge outcome (see Tab. 1). A 
biomedical challenge task reported a median of 64% (IQR: (49%, 72%); min: 21%, max: 92%) of 
these parameters. 6% of the parameters were reported for all tasks and 43% of all parameters 
were reported for less than 50% of all tasks. The list of parameters which are generally not 
reported includes some that are crucial for interpretation of results. For example, 8% of all tasks 
providing an aggregated ranking across multiple metrics did not report the rank aggregation 
method they used (i.e. the method according to which the winner has been determined). 85% of 
the tasks did not give instructions on whether training data provided by challenge organizers may 
have been supplemented by other publicly available or private data, although the training data 
used is key to the success of any machine learning algorithm (see e.g. [Russakovsky et al. 2015]). 
In 66% of all tasks, there was no description on how the reference (i.e. gold standard) annotation 
was performed although the quality of annotation in the field of biomedical image analysis varies 
dependent on the user [Grünberg et al. 2017]. 45% of tasks with multiple annotators did not 
describe how the annotations were aggregated. Also, the level of expertise of the observers that 
annotated the reference data was often (19%) not described. 
 
 
Category Parameter name Coverage [%] 
Challenge organization Challenge name* 100 
 Challenge website* 99 
 Organizing institutions and contact person* 97 
 Life cycle type* 100 
 Challenge venue or platform 99 
 Challenge schedule* 81 
 Ethical approval* 32 
 Data usage agreement 60 
Participation conditions Interaction level policy* 62 
 Organizer participation policy* 6 
 Training data policy* 15 
 Pre-evaluation method 5 
 Submission format* 91 
 Submission instructions 91 
 Evaluation software 26 
Validation objective Field(s) of application* 97 
 Task category(ies)* 100 
 Target cohort* 65 
 Algorithm target(s)* 99 
 Data origin* 98 
 Assessment aim(s)* 38 
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Study conditions Validation cohort* 88 
 Center(s)* 44 
 Imaging modality(ies)* 99 
 Context information* 35 
 Acquisition device(s) 25 
 Acquisition protocol(s) 72 
 Operator(s) 7 
Validation data sets Distribution of training and test cases* 18 
 Category of training data generation method* 89 
 Number of training cases* 89 
 Characteristics of training cases* 79 
 Annotation policy for training cases* 34 
 Annotator(s) of training cases* 81 
 Annotation aggregation method(s) for training cases* 29 
 Category of reference generation method* 87 
 Number of test cases* 77 
 Characteristics of test cases* 77 
 Annotation policy for test cases* 34 
 Annotator(s) of test cases* 78 
 Annotation aggregation method(s) for test cases* 34 
 Data pre-processing method(s) 24 
 Potential sources of reference errors 28 
Assessment method Metric(s)* 96 
 Justification of metrics* 23 
 Rank computation method* 36 
 Interaction level handling* 44 
 Missing data handling* 18 
 Uncertainty handling* 5 
 Statistical test(s)* 6 
Challenge outcome Information on participants 88 
 Results 87 
 Publication 74 
 
Tab. 1: List of parameters that were identified as relevant when reporting a challenge along with 
the percentage of challenge tasks for which information on the parameter has been reported (red: 
< 50%; orange: between 50% and 90%; green: > 90%). Parameter definitions can be found in 
Suppl.1.  
*: Parameters used for structured challenge submission for the MICCAI 2018 challenges. 
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Large variability in challenge design 
In total, 97 different metrics have been used for performance assessment (three on average per 
task). Metric design is very heterogeneous, particularly across comparable challenges, and 
justification for a particular metric is typically (77%) not provided. Roughly half of all metrics (51%) 
were only applied on a single task. Even in the main field of medical image segmentation, 33% of 
the 38 different metrics used were only applied once. The fact that different names may sometimes 
refer to the same metric was compensated for in these computations. 38% of all tasks provided a 
final ranking of the participants and thus determined a challenge winner. 57% of all tasks that 
provide a ranking do so on the basis of a single metric. In this case, either metric-based 
(aggregate, then rank; 70%) or case-based (rank per case, then aggregate; 1%) is typically 
performed (see Online Methods). Overall, 10 different methods for determining the final rank (last 
step in computation) of an algorithm based on multiple metrics were applied. 
 
Minor changes in metrics may make the last the first 
Besides the Dice Similarity Coefficient (DSC) [Dice 1945], which was used in 92% of all 383 
segmentation tasks (2015: 100%), the Hausdorff Distance (HD) [Huttenlocher et al. 1993, 
Dubuisson and Jain 1994] is the most commonly applied metric in segmentation tasks (47%). It 
was used either in its original formulation (42%) or as the 95% variant (HD95) (5%) (38%/8% in the 
2015 segmentation challenges). We determined a single-metric ranking based on both versions for 
all 2015 segmentation challenges and found radical differences in the rankings as shown in Fig. 
2a). In one case, the worst-performing algorithm according to the HD (10th place) was ranked first 
in a ranking based on the HD95. 
 
Different aggregation methods produce different winners 
One central result of most challenges is the final ranking they produce. Winners are considered 
"state of the art" and novel contributions are then benchmarked according to them. The significant 
design choices related to the ranking scheme based on one or multiple metric(s) are as follows: 
whether to perform metric-based (aggregate, then rank) or case-based (rank, then aggregate) and 
whether to take the mean or the median. Statistical analysis with Kendall’s tau (rank correlation 
coefficient [Kendall 1938]) using all segmentation challenges conducted in 2015 revealed that the 
test case aggregation method has a substantial effect on the final ranking, as shown in Fig. 2b)/c). 
In some cases, almost all teams change their ranking position when the aggregation method is 
changed. According to bootstrapping experiments (Fig. 3 and 4), single-metric rankings are 
statistically highly significantly more robust when (1) the mean rather than the median is used for 
aggregation and (2) the ranking is performed after the aggregation. 
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Fig. 2: Robustness of rankings with respect to several challenge design choices. One data point 
corresponds to one segmentation task organized in 2015 (n = 56). a) Ranking (metric-based) with 
the standard Hausdorff Distance (HD) vs. its 95% variant (HD95). b) Mean vs. median in metric-
based ranking based on the HD. c) Case-based (rank per case, then aggregate with mean) vs. 
metric-based (aggregate with mean, then rank) ranking in single-metric ranking based on the HD. 
d) Metric values per algorithm and rankings for reference annotations performed by two different 
observers. In the box plots a)-c), descriptive statistics for Kendall’s tau, which quantifies differences 
between rankings (1: identical ranking; -1: inverse ranking), is shown. Key examples illustrate that 
slight changes in challenge design may lead to the worst algorithm becoming the winner (a) or to 
almost all teams changing their ranking position (d). Even for relatively high values of Kendall’s tau 
((b): tau = 0.74; (c): tau = 0.85), critical changes in the ranking may occur. 
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Different annotators produce different winners 
In most segmentation tasks (62%), it remains unclear how many observers annotated the 
reference data. Statistical analysis of the 2015 segmentation challenges, however, revealed that 
different observers may produce substantially different rankings, as illustrated in Fig. 2(d). In 
experiments performed with all 2015 segmentation challenges that had used multiple observers for 
annotation (three tasks with two observers, one with five observers), different observers produced 
different rankings in 15%, 46% and 62% of the 13 pairwise comparisons between observers, when 
using a single-metric ranking with mean aggregation based on the DSC, the HD and the HD95, 
respectively. In these cases, the ranges of Kendall’s tau were [0.78, 1], [-0.02, 1] and [0.07,1], 
respectively. 
 
Removing one test case can change the winner 
Ideally, a challenge ranking should reflect the algorithms’ performances for a task and thus be 
independent of the specific data sets used for validation. However, a re-evaluation of all 
segmentation challenges conducted in 2015 revealed that rankings are highly sensitive to the test 
data applied (Fig. 4). According to bootstrapping experiments with the most commonly applied 
segmentation metrics, the first rank is stable (the winner stays the winner) for 21%, 11% and 9% of 
the tasks when generating a ranking based on the DSC, the HD or the 95% variant of the HD, 
respectively. For the most frequently used metric (DSC; 100% of all 2015 segmentation 
challenges), a median of 15% and up to 100% of the other teams were ranked first in at least 1% 
of the bootstrap partitions. Even when leaving out only a single test case (and thus computing the 
ranking with one test case less), other teams than the winning team were ranked first in up to 16% 
of the cases. In one task, leaving a single test case out led to 67% of the teams other than the 
winning team ranking first. 
 
 
Fig. 3: The ranking scheme is a deciding factor for the ranking robustness. According to 
bootstrapping experiments with 2015 segmentation challenge data, single-metric based rankings 
(those shown here are for the DSC) are significantly more robust when the mean rather than the 
median is used for aggregation (left) and when the ranking is performed after aggregation rather 
than before (right). One data point represents the robustness of one task, quantified by the 
percentage of simulations in bootstrapping experiments in which the winner remains the winner. 
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Fig. 4: Robustness of rankings with respect to the data used when a single-metric ranking scheme 
based on whether the Dice Similarity Coefficient (DSC) (left), the Hausdorff Distance (HD) (middle) 
or the 95% variant of the HD (right) is applied. One data point corresponds to one segmentation 
task organized in 2015 (n = 56). Metric-based aggregation with mean was performed in all 
experiments. Top: Percentage of simulations in bootstrapping experiments in which the winner 
(according to the respective metric) remains the winner. Bottom: Percentage of other participating 
teams that were ranked first in the simulations. 
 
Lack of missing data handling allows for rank manipulation 
82% of all tasks provide no information about how missing data is handled. While missing data 
handling is straightforward in case-based aggregation (the algorithms for which no results were 
submitted receive the last rank for that test case) it is more challenging in metric-based 
aggregation, especially when no “worst possible value” can be defined for a metric. For this 
reason, several challenge designs simply ignore missing values when aggregating values. A re-
evaluation of all 2015 segmentation challenges revealed that 25% of all 419 non-winning 
algorithms would have been ranked first if they had systematically just submitted the most 
plausible results (ranking scheme: aggregate DSC with mean, then rank). In 9% of the 56 tasks, 
every single participating team could have been ranked first if they had not submitted the poorest 
cases. 
 
Researchers request quality control 
Our experimental analysis of challenges was complemented by a questionnaire (see Online 
Methods). It was submitted by a total of 295 participants from 23 countries. 92% of participants 
agreed that biomedical challenge design should be improved in general, 87% of all participants 
would appreciate best practice guidelines, and 71% agreed that challenges should undergo more 
12 
quality control. A variety of issues were identified for the categories data, annotation, evaluation, 
and documentation (cf. Fig. 5). Many concerns involved the representativeness of the data, the 
quality of the (annotated) reference data, the choice of metrics and ranking schemes and the lack 
of completeness and transparency in reporting challenge results. Details are provided in Suppl. 2 
and 3. 
 
 
 
Fig. 5: Main results of the international questionnaire on biomedical challenges. Issues raised by 
the participants were related to the challenge data, the data annotation, the evaluation (including 
choice of metrics and ranking schemes) and the documentation of challenge results. 
 
Complete reporting as a first step towards better practices 
Based on the findings of this study and the answers to the questionnaire, we have identified 
several best practice recommendations (see Tab. 2) corresponding to the main problems in 
biomedical challenge design. The establishment of common standards and clear guidelines is 
currently hampered by open research questions that still need addressing. However, one primary 
practice that can be universally recommended is comprehensive reporting of the challenge design 
and results. Our practical and concrete recommendation is therefore to publish the complete 
challenge design before the challenge by instantiating the list of parameters proposed in this paper 
(Tab. 1). Three example instantiations are provided in Suppl. 1. The MICCAI 2018 satellite event 
team used the parameter list in the challenge proposal submission system to test its applicability. 
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The submission system required a potential MICCAI 2018 challenge organizer to instantiate at 
least 90% of a reduced set of 40 parameters (cf. Tab. 1) that were regarded as essential for 
judging the quality of a challenge design proposal. The median percentage of parameters 
instantiated was 100% (min: 98%) (16 submitted challenges). Previous tasks analyzed in this 
paper reported a median of 53% of these parameters. 
 
Problem Best practice recommendation(s) Open research question(s) 
 
Incomplete 
reporting 
Instantiate the full parameter list (Tab. 1) when reporting 
on a challenge to maximize transparency, interpretability 
and reproducibility. 
How to describe the data in a structured and 
standardized manner (e.g. using ontologies)? 
[Munafò et al. 2017, Zendel et al. 2017, Jannin, 
Grova and Maurer 2006, Jannin and Korb 2008] 
Unclear 
challenge goal 
 
Define a relevant, specific and feasible goal which the 
challenge will address. 
 
Decide on whether to perform an insight challenge, the 
objective of which is to gain insight into a problem and 
potentially identify a research direction, or a deployment 
challenge, the objective of which is to solve a problem 
and identify the best-performing algorithms based on a 
huge benchmarking set. 
How to judge the utility (scientific advancement, 
clinical relevance, biological or clinical insights, 
implications for patient care, commercial readiness) 
of a challenge? [Haynes and Haines 1998, Ioannidis 
2016, Norman and Verganti 2014, Cutler and 
McClellan 2001]  
 
For deployment challenges, how to determine 
feasibility of clinical deployment in the near, medium 
and long term? [Shekelle et al. 2006, Black et al. 
2011, Garg et al. 2005] 
Lack of 
representative- 
ness 
Use data from multiple sources (e.g. sites, devices). 
 
Ensure that the selected data collection covers the 
natural variability of imaged objects. 
 
Be aware of the effects of imbalanced training data 
[Masko and Hensman 2015] when designing the training 
data set. 
 
How to determine the required number of 
training/test cases for a given task? [Jain and 
Chandrasekaran 1982, Raudys 1991, Kalayeh and 
Landgrebe 2012, Bonnet 2002, Shoukri et al. 2004, 
Sim and Wright 2005] 
 
How to avoid bias in the training/test data? [Deng et 
al. 2009, Everingham et al. 2010, Chum et al. 2007, 
Torralba and Efros 2011, Zendel et al. 2017] 
 
How to design a challenge that covers the 
heterogeneity of clinical practice? 
Low annotation 
quality 
 
Use multiple annotators per test case. 
 
Provide clear guidelines for the annotators. 
 
Choose the tools for speeding up annotations carefully 
as they may lead to bias in the annotations (cf. e.g. 
[Grünberg et al. 2017]). 
 
Find a good compromise between quantity and quality. 
Consider maximizing annotation quality for the test data 
(‘gold corpus’) while increasing quantity at the expense 
of quality in the training data (‘silver corpus’). 
 
Assign certified radiologists with standardized training a 
key role in imaging data annotation to maximize inter-
reader agreement [Bamberg et al. 2015, Schlett et al. 
2016, Melsaether et al. 2014] 
How to choose the number of observers for a 
specific task? [Welinder and Perona 2010, Bartlett 
and Frost 2008, Van den Heuvel and Trip 2002, 
Walter et al. 1998] 
 
How to best combine multiple annotations? [Asman 
and Landman 2011, Lampert et al. 2016, Sheng et 
al. 2008, Tian and Zhu 2015, Warfield, Zou and 
Wells 2004] 
 
How to represent, quantify and compensate 
uncertainty in annotations? [Long et al. 2013, Peng 
and Zhang 2012] 
 
How to provide incentives (especially for clinicians) 
for data acquisition and annotation? [Von Ahn and 
Dabbish 2004] 
 
How to make data annotation more efficient? [Deng 
et al. 2009, Everingham et al. 2010, Branson and 
Perona 2017, Grünberg et al. 2017] 
Suboptimal 
metric(s)  
 
Make sure the metrics reflect the challenge goal. 
 
Choose metrics that capture the clinically/biologically 
relevant differences. 
 
Be aware of metric-specific biases in favor of/against 
various properties [Taha and Hanbury 2015]. 
 
In segmentation challenges, be aware (1) that the DSC 
yields more robust rankings than the HD and (2) that the 
HD yields more robust rankings than the HD95 (Fig. 3). 
 
Consider including supplementary usability metrics 
How to determine the best (variant of a) metric or a 
set of metrics for a given task? [Taha et al. 2014, 
Pont-Tuset and Marques 2013, Cehovin et al. 2014] 
 
How to better consider clinical relevance in the 
performance metrics (e.g. by having radiologists 
quantify the negative effect of segmentation errors)? 
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related to computation time, memory consumption, 
number of supported platforms and number of 
parameters, etc. [Ulman et al. 2017]. 
Poor ranking 
schemes 
Be aware of mutually dependent metrics [Cehovin et al. 
2014]. 
 
Ensure robust rankings. 
- Perform metric-based aggregation rather than case-
based aggregation to obtain more robust rankings 
(Fig. 2). 
- Use the mean rather than the median to obtain more 
robust rankings (Fig. 2). 
 
Develop a strategy to handle missing values.  
 
When applying case-based rankings, consider the 
tradeoff between robustness (Fig. 2) and good missing 
value handling. 
 
Be aware that a statistically significant difference in a 
metric value may not be clinically/biologically relevant. 
Vice versa, a clinically relevant difference in 
performance may not be statistically significant due to 
small sample size. 
 
Decide whether a single ranking (one winner) is 
needed/meaningful.  
 
Report multiple metric results and provide appropriate 
visualizations to highlight strengths and weaknesses of 
different methods [Johannsen et al. 2017, Honauer et al. 
2016, Honauer et al. 2015]. 
How to handle missing data when aggregating metric 
values? 
 
How to determine an appropriate ranking scheme for 
a given application? [Langville et al. 2012, Pang and 
Ling 2013, Cabezas et al. 2011, Kristan et al. 2016] 
 
How to group algorithms (i.e. assign the identical 
rank) in a sensible manner? [Kristan et al. 2016, 
Neilson and Yang 2008, Cabezas et al. 2011] 
Poor uncertainty 
handling 
Quantify the uncertainties of annotations and rankings 
and make them explicit: 
- Report inter-observer variability for reference 
annotations. 
- Perform bootstrapping to quantify ranking stability (cf. 
Fig. 3). 
 
Consider generating fuzzy (probabilistic) reference data 
and allowing submission of fuzzy results [Taha and 
Hanbury 2017, Sheng et al. 2008]. 
How to incorporate known uncertainties in the 
reference annotations in the metric computation? 
[Peng and Zhang 2012] 
 
How to quantify the uncertainty of a ranking?  
[Kristan et al. 2016, Pang and Ling 2013, Cabezas et 
al. 2011] 
 
Cheating and 
overfitting 
Publish the challenge design before the challenge 
according to the parameters in Tab. 1. 
 
Aim for Docker-based solutions [Hanbury et al. 2017] or 
on-site challenges to reduce the risk of cheating. 
 
Otherwise release more test cases than are used for 
validation (keep the real ones for which annotations are 
available confidential). 
 
Do not participate in your own challenge, or otherwise, 
make the participation transparent. 
 
Encourage open source release of the algorithms’ code. 
What is a good lifecycle for a challenge (considering 
both the dynamics of algorithm development and the 
overfitting problem)? [Deng et al. 2009, Everingham 
et al. 2010, Fei-Fei, Fergus and Perona 2006, 
Perazzi et al. 2016, Dwork et al. 2015] 
Overhead for 
participants and 
organizers 
Consider using an existing web-based platform to run 
the challenge (e.g. [CodaLab], [kaggle], [Grand 
Challenges], [COVALIC]). 
 
Consider cloud-based infrastructure for huge data sets 
and computationally demanding tasks (e.g. [crowdAI]). 
 
Choose or define a suitable algorithm output format and 
provide tools for the computation of metrics in this 
format. Include sample algorithm(s)/workflow(s).  
How to establish globally respected standards? 
 
Tab. 2: Problems related to current challenge design and organization, best practice 
recommendations for them and open research challenges (including literature for further reading) 
relating to them. 
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3. Discussion 
The key findings of this paper can be summarized as follows: 
1. Relevance of challenges: Challenges play an increasingly important role in the field of 
biomedical image analysis, covering a huge range of problems, algorithm classes and 
imaging modalities (Fig. 1). 
2. Challenge reporting: Common practice related to challenge reporting is poor and does not 
allow for adequate interpretation and reproducibility of results (Tab. 1). 
3. Challenge design: Challenge design is very heterogeneous and lacks common standards, 
although these are requested by the community (Tab. 1, Fig. 5). 
4. Robustness of rankings: Rankings are sensitive to a range of challenge design parameters, 
such as the metric variant applied, the type of test case aggregation performed and the 
observer annotating the data. The choice of metric and aggregation scheme has a 
significant influence on the ranking’s stability (Fig. 2-4). 
5. Best practice recommendations: Based on the findings of this paper and an international 
survey, we present a list of best practice recommendations and open research challenges. 
The most universal recommendation is the instantiation of a list of 53 challenge parameters 
before challenge execution to ensure fairness and transparency along with interpretability 
and reproducibility of results (Tab. 2). 
 
While this paper concentrates on the field of biomedical image analysis challenges, its impact can 
be expected to go beyond this field. In fact, many findings of this paper apply not only to 
challenges but to the topic of validation in general. It may be expected that more effort is typically 
invested when designing and executing challenges (which, by nature, have a high level of visibility 
and go hand in hand with publication of the data) compared to the effort invested in performing “in-
house studies” dedicated to validation of an individual algorithm. Therefore, concerns involving the 
meaningfulness of research results in general may be raised. This may also hold true for other 
research fields, both inside and outside the life sciences, as supported by related literature [Munafò 
et al. 2017, Ioannidis 2005, Armstrong et al. 2009, Blanco and Zaragoza 2011, Boutros et al. 
2014]. 
In our parameter list (Tab. 1), we have provided a first recommendation to improve the quality of 
challenge design and its execution and documentation. More international guidelines for challenge 
organization should be established and a rigorous assessment of challenges organized in the 
scope of big conferences should be performed in order to move the field towards next-generation 
biomedical image analysis challenges. To improve data quality, it should be made possible to give 
open feedback on the data provided by challenges (e.g. ability to report erroneous annotations). 
Crucially, incentives for organizing and publishing high-quality challenges should be provided. 
Finally, research dedicated to addressing some of the open issues within challenge design should 
be actively supported. 
In conclusion, challenges are an essential component in the field of biomedical image analysis, but 
major research challenges and systemic hurdles need to be overcome to fully exploit their potential 
as valid benchmarking tools. 
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Online Methods 
 
Definitions 
We use the following terms throughout the paper: 
Challenge: Open competition on a dedicated scientific problem in the field of biomedical image 
analysis. A challenge is typically organized by a consortium that issues a dedicated call for 
participation. A challenge may deal with multiple different tasks for which separate assessment 
results are provided. For example, a challenge may target the problem of segmentation of 
human organs in computed tomography (CT) images. It may include several tasks 
corresponding to the different organs of interest. 
Task: Subproblem to be solved in the scope of a challenge for which a dedicated 
ranking/leaderboard is provided (if any). The assessment method (e.g. metric(s) applied) may 
vary across different tasks of a challenge. 
Case: Dataset for which the algorithm(s) of interest produce one result in either the training phase 
(if any) or the test phase. It must include one or multiple images of a biomedical imaging 
modality (e.g. a CT and a magnetic resonance imaging (MRI) image of the same structure) and 
typically comprises a gold standard annotation (usually required for test cases).  
Metric: A measure (not necessarily metric in the strict mathematical sense) used to compute the 
performance of a given algorithm for a given case, typically based on the known correct answer. 
Often metrics are normalized to yield values in the interval from 0 (worst performance) to 1 (best 
performance). 
Metric-based vs. case-based aggregation: To rank an algorithm participating in a challenge based 
on the performance on a set of test cases according to one or multiple metrics, it is necessary to 
aggregate values to derive a final rank. In single-metric rankings, we distinguish the following 
two categories, which cover most ranking schemes applied. Metric-based aggregation begins 
with aggregating metric values over all test cases (e.g. with the mean or median). Next, a rank 
for each algorithm is computed. In contrast, case-based aggregation begins with computing a 
rank for each test case for each algorithm. The final rank is determined by aggregating test case 
ranks. 
 
Inclusion criteria 
Inclusion criteria for “Experiment: Comprehensive reporting” 
Our aim was to capture all biomedical image analysis challenges that have been conducted up to 
2016. We did not include 2017 challenges as our focus is on information provided in scientific 
papers, which may have a delay of more than a year to be published after challenge execution. To 
acquire the data, we analyzed the websites hosting/representing biomedical image analysis 
challenges, namely grand-challenge.org, dreamchallenges.org and kaggle.com as well as websites 
of main conferences in the field of biomedical image analysis, namely Medical Image Computing 
and Computer Assisted Intervention (MICCAI), International Symposium on Biomedical Imaging 
(ISBI), International Society for Optics and Photonics (SPIE) Medical Imaging, Cross Language 
Evaluation Forum (CLEF), International Conference on Pattern Recognition (ICPR), The American 
Association of Physicists in Medicine (AAPM), the Single Molecule Localization Microscopy 
Symposium (SMLMS) and the BioImage Informatics Conference (BII). This yielded a list of 150 
challenges with 549 tasks. 
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Inclusion criteria for “Experiment: Sensitivity of challenge ranking” 
All organizers of 2015 segmentation challenges (n = 14) were asked to provide the challenge 
results (per algorithm and test case) and (re-)compute a defined set of common performance 
measures, including the Dice Similarity Coefficient (DSC) and the Hausdorff Distance (HD) in the 
original version [Huttenlocher et al. 1993] and the the 95% variant (HD95) [Dubuisson and Jain 
1994]. While the DSC was used in the original design of all 2015 challenges, the HD/HD95 was not 
always applied. 13 challenges were able to provide the measures as requested. These challenges 
are composed of 124 tasks in total. The specific inclusion criteria on challenge and task level are 
provided in Tab. 1 and 2. 
 
# Criterion Number of 
affected 
tasks/challenges 
1 If a challenge task has on- and off-site part, the results of the part with 
the most participating algorithms are used. 
1/1 
2 If multiple reference annotations are provided for a challenge task and 
no merged annotation is available, the results derived from the second2 
annotator are used. 
2/2 
3 If multiple reference annotations are provided for a challenge task and 
a merged annotation is available, the results derived from the merged 
annotation are used. 
1/1 
4 If an algorithm produced invalid values for a metric in all test cases of a 
challenge task, this algorithm is omitted in the ranking. 
1/1 
Tab. 1: Inclusion criteria on challenge level. 
 
# Criterion Number of 
excluded tasks 
1 Number of algorithms >= 3 42 
2 Number of test cases > 1 (for bootstrapping and cross-validation 
approaches) 
25 
3 No explicit argumentation against the usage of Hausdorff Distance as 
metric 
1 
Tab. 2: Inclusion criteria on task level. 
 
Challenge parameter list 
One key purpose of this paper was to develop a list of parameters that can be instantiated for 
describing the design and results of a challenge in a comprehensive manner, thus facilitating 
interpretability and reproducibility of results. To this end, the following procedure was followed: 
Initialization: The parameters for describing reference-based validation studies presented in 
[Jannin, Grova and Maurer 2006] served as an initial set. 
                                               
2 In one challenge, the first annotator produced radically different annotations from all other observers. This is why we 
used the second observer of all challenges. 
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Adding challenge-specific parameters: During analysis of challenge websites and papers, the initial 
list was complemented such that the information available on a challenge could be 
comprehensively formalized. 
Refinement based on challenge capturing: A tool was designed to formalize existing challenges 
with the current parameter list. During this process, the list was further refined. 
Refinement with international questionnaire: Finally, a questionnaire was designed and sent to all 
co-authors to finalize the list. All participants were asked to comment on the name, the description, 
the importance and possible instantiations of each parameter. Adding further parameters was also 
allowed. 
Finalization with ontological modeling: Based on the final list, an ontology for describing biomedical 
image analysis challenges was developed. The latter was used for structured submission of 
MICCAI 2018 biomedical challenges. 
 
Statistical methods 
To quantify the robustness of a ranking, the following statistical methods were used: 
Kendall’s tau analysis: To quantify the agreement of two rankings (e.g. for two different 
aggregation methods or two different metric variants), Kendall’s tau (also named Kendall’s rank 
correlation or simply tau) [Kendall 1938] was determined as recommended in [Langville et al. 
2012]. Tau was designed to be independent of the number of entities ranked and may take values 
between 1 (perfect agreement, i.e. same ranking) and -1 (reverse ranking). 
Bootstrapping: For analysis of the variability of a ranking scheme (e.g. as a function of the metric 
applied), the following bootstrap approach was chosen: For a given task, the original ranking based 
on all test cases and a given ranking scheme as well as the winning algorithm according to this 
ranking scheme was determined. In all analyses, 1000 bootstrap samples were drawn from the 
data sets and the ranking scheme was applied to each bootstrap sample. It should be noted that 
on average, 63.2% of distinct data sets are retained in a bootstrap sample. For summary of the 
ranking scheme variability, the frequency of rank 1 in the bootstrap samples for the original winner 
(“the winner remains the winner”) as well as the proportion of algorithms that achieved rank 1 in the 
bootstraps but were not winning in the original ranking was determined. Competitions with multiple 
winners according to the original ranking were not included in the analysis (this occured in just one 
task). For comparison of the stability of different ranking schemes, the same bootstrap samples 
were evaluated with different ranking schemes and a paired comparison between the proportion of 
the “winner remaining the winner” was performed by Wilcoxon signed rank test. Results were 
considered significant for p < 0.05. 
Leave-one-out: For a given task, the original ranking based on all test cases and a given ranking 
scheme and the winning algorithm according to this ranking scheme was determined. The number 
of datasets was reduced by one and the ranking scheme was applied to this subset of datasets. 
The same summary measures as for the bootstrapping approach were determined. 
Note that we did not rely on results of statistical testing approaches to quantify the stability of a 
given ranking scheme. The reasons for this decision were the following: 
(a) The number of datasets varies widely between different tasks and due to correlation of power 
and sample size, results of statistical tests between different tasks are not comparable by design. 
(b) If one was to use statistical testing, the appropriate approach would be to use a mixed model 
with a random factor for the data set and test the global hypothesis that all algorithms produce the 
same result, followed by post-hoc all pairwise comparisons. Pairwise comparisons would have to 
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be adjusted for multiplicity and adjustment depends on the number of algorithms in the task. Again, 
results of statistical testing between different tasks are not comparable by design. 
(c) We have evaluated the concordance of the bootstrap analysis for variability of ranking with a 
statistical testing approach and found examples where there was a highly significant difference 
between the winner and the second, but bootstrap analysis showed that ranking was very variable, 
and vice versa. 
Boxplots with and without dots were produced to visualize results. In all boxplots, the boldfaced 
black line represents the median while the box represents the first and third quartile. The upper 
whisker extends to the largest observation <= Median +1.5 IQR, and likewise the lower whisker to 
the smallest observation >= Median -1.5 IQR. In horizontal boxplots, the mean is shown in addition 
as boldfaced grey line. 
All statistical analyses were performed with R version 3.4.3 (The R Foundation for Statistical 
Computing 2017). The figures were produced with Excel, R, Plotly (Python) and Adobe Illustrator 
2017. 
 
Experiment: Comprehensive reporting 
The key research questions corresponding to the comprehensive challenge analysis were: 
RQ1: What is the role of challenges for the field of biomedical image analysis (e.g. How many 
challenges conducted to date? In which fields? For which algorithm categories? Based on which 
modalities?) 
RQ2: What is common practice related to challenge design (e.g. choice of metric(s) and ranking 
methods, number of training/test images, annotation practice etc.)? Are there common standards? 
RQ3: Does common practice related to challenge reporting allow for reproducibility and adequate 
interpretation of results? 
To answer these questions, a tool for instantiating the challenge parameter list introduced in the 
previous section was used by five engineers and a medical student to formalize all challenges that 
met our inclusion criteria as follows: (1) Initially, each challenge was independently formalized by 
two different observers. (2) The formalization results were automatically compared. In ambiguous 
cases, when the observers could not agree on the instantiation of a parameter - a third observer 
was consulted, and a decision was made. When refinements to the parameter list were made, the 
process was repeated for missing values. Based on the formalized challenge data set, a 
descriptive statistical analysis was performed to characterize common practice related to challenge 
design and reporting. 
 
Experiment: Sensitivity of challenge ranking 
The primary research questions corresponding to the experiments on challenge rankings were: 
RQ4: How robust are challenge rankings? What is the effect of 
(a) the specific test cases used? 
(b) the specific metric variant(s) applied? 
(c) the rank aggregation method chosen (e.g. aggregation of metric values with the mean vs 
median)? 
(d) the observer who generated the reference annotation? 
RQ5: Does the robustness of challenge rankings vary with different (commonly applied) metrics 
and ranking schemes? 
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RQ6: Can common practice on missing data handling be exploited to manipulate rankings? 
As published data on challenges typically do not include metric results for individual data sets, we 
addressed these open research questions by approaching all organizers of segmentation 
challenges conducted in 2015 and asking them to provide detailed performance data on their tasks 
(124 in total). Note in this context that segmentation is by far the most important algorithm category 
(70% of all biomedical image analysis challenges) as detailed in the Results section. Our 
comprehensive challenge analysis further revealed single-metric ranking with mean and metric-
based aggregation as the most frequently used ranking scheme. This is hence considered the 
default ranking scheme in this paper.  
Our analysis further identified the DSC (92%) and the HD (47%) as the most commonly used 
segmentation metrics. The latter can either be applied in the original version (42%) or the 95% 
variant (HD95) (5%). 
To be able to investigate the sensitivity of rankings with respect to several challenge design 
choices, the 2015 segmentation challenge organizers were asked to provide the assessment data 
(results for DSC, HD and HD95) on a per data set basis for their challenge. The research 
questions RQ4-6 were then addressed with the following experiments: 
RQ4: For all 56 segmentation tasks that met our inclusion criteria, we generated single-metric 
rankings with the default ranking scheme based on the DSC and the HD. We then used Kendall’s 
tau to investigate the effect of changing (1) the metric variant (HD vs HD95), (2) the aggregation 
operator (mean vs median), (3) the aggregation category (metric-based vs case-based) and (4) the 
observer (in case multiple annotations were available). Note in this context that we focused on 
single-metric rankings in order to perform a statistical analysis that enables a valid comparison 
across challenges. 
RQ5: To quantify the robustness of rankings as a function of the metric, we generated single-
metric rankings with the default ranking scheme based on the DSC, the HD and the HD95. We 
then applied bootstrapping and leave-one-out analysis to quantify ranking robustness as detailed in 
Statistical Methods. Analogously, we compared the robustness of rankings for different 
aggregation methods (metric-based vs case-based) and aggregation operators (mean vs median). 
RQ6: 82% of all biomedical image analysis tasks (see Results) do not report any information on 
missing values when determining a challenge ranking. In metric-based ranking (although not 
reported), it is common to simply ignore missing values. To investigate whether this common 
practice may be exploited by challenge participants to manipulate rankings, we performed the 
following analysis: For each algorithm and each task of each 2015 segmentation challenge that 
met our inclusion criteria, we determined the default ranking and artificially removed those test set 
results whose DSC was below a threshold of t = 0.5. Note that it can be assumed that these cases 
could have been relatively easily identified by visual inspection without comparing them to the 
reference annotations. We then compared the new ranking position of the algorithm with the 
position in the original (default) ranking. 
 
International Survey 
As a basis for deriving best practice recommendations related to challenge design and 
organization, we designed a questionnaire (see Suppl. 2) to gather known potential issues. It was 
distributed to colleagues of all co-authors, the challenges chairs of the past 3 MICCAI conferences 
as well as to the following mailing lists: ImageWorld, the mailing lists of the MICCAI society, the 
international society for computer aided surgery (ISCAS), the UK Euro-BioImaging project and the 
conferences Medical Image Understanding and Analysis (MIUA) and Bildverarbeitung für die 
Medizin (BVM). The link to the questionnaire was further published on grand-challenge.org. 
21 
Supplement 1 
 
# 
Parameter 
name 
Description  Representative instantiations 
Challenge organization 
1 Challenge 
name* 
Full name of the challenge with year.  Example: MICCAI Endoscopic Vision Challenge 
2015 
 
2 Challenge 
website* 
URL of challenge website (if any).    URL to challenge website 
 Private link to website under construction 
 No website 
 
3 Organizing 
institutions and 
contact person* 
Information on the organizing team including 
contact person and other team members. 
 Should include:  
 Contact person with affiliation 
 Team members with affiliations 
 
4 Life cycle type* 
 
Submission cycle of the challenge. Not every 
challenge closes after the submission deadline 
(one-time event). Sometimes it is possible to 
submit results after the deadline (open call) or 
the challenge is repeated with some 
modifications (repeated event).  
 
Example 1 - Brain tumor segmentation: One-
time event 
 
Example 2 - Instrument tracking: Open call 
 
Example 3 - Modality classification in biomedical 
literature: Repeated event (each year; third 
time) 
 
   One-time event 
 Repeated event 
 Open call  
 
5 Challenge 
venue or 
platform 
 
Event (e.g. conference) or platform that is 
associated with the challenge. 
 
Example 1 - Brain tumor segmentation: DREAM 
 
Example 2 - Instrument tracking: None (online 
competition) 
 
Example 3 - Modality classification in biomedical 
literature: ImageCLEF 
   Medical Image Computing and Computer 
Assisted Intervention (MICCAI) 
 International Symposium on Biomedical 
Imaging (ISBI) 
 Dialogue on Reverse Engineering 
Assessments and Methods (DREAM) 
 Image Cross Language Evaluation Forum 
(ImageCLEF) 
 International conference on pattern 
recognition (ICPR) 
 Kaggle 
 The International Society for Optical 
Engineering (SPIE) Medical Imaging 
 Single Molecule Localization Microscopy 
Symposium (SMLMS) 
 American Association of Physicists in 
Medicine (AAPM) 
 BioImage Informatics (BII) 
 
6 Challenge 
schedule* 
Timetable for the challenge which includes the 
release of training and test cases, the 
submission dates, possibly associated 
workshop days, release of results and other 
important dates. 
 Should include: 
 Training data release(s) 
 Test data release(s) 
 Submission deadline 
 Conference day (if any) 
 
7 Ethics approval* Information on ethics approval, 
preferably Institutional Review Board, location, 
date and number of the ethics approval. 
 
Example 1 - Brain tumor segmentation: <URL to 
ethics approval> 
   No ethics needed (due to in silico 
validation) 
 URL to ethics approval document 
 No ethics required (data downloaded from 
a public database) 
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Example 2 - Instrument tracking: Reference to 
ethics of the data source (data for the challenge 
is publicly available) 
 
Example 3 - Modality classification in biomedical 
literature: Not needed as the images are from 
biomedical journals and publications require 
internal ethics approval. In PubMed central 
(open access biomedical literature), all images 
can be redistributed when citing the source; 
each image has a Creative Commons license 
attached to the image. 
 
8 Data usage 
agreement 
 
Instructions on how the data can be used and 
distributed by the teams that participate in the 
challenge and by others. 
 
Example 1 - Brain tumor segmentation: The 
data may only be used for the challenge itself 
and may not be redistributed. 
 
Example 2 - Instrument tracking: The data can 
be reused for other purposes but the challenge 
has to be mentioned in the acknowledgements.  
 
Example 3 - Modality classification in biomedical 
literature: <URL to data usage agreement> 
 
   Challenge data must not be redistributed to 
persons not belonging to the registered 
team. 
 Challenge data may be used for all 
purposes provided that the challenge is 
referenced. 
 URL to data usage agreement 
Participation conditions 
9 Interaction level 
policy* 
Allowed user interaction of the algorithms 
assessed. 
 
Example 1 - Brain tumor segmentation: Both 
automatic and semi-automatic algorithms can 
participate in the challenge. 
 
Example 2 - Instrument tracking: Only fully 
automatic algorithms are allowed to participate. 
 
Example 3 - Modality classification in biomedical 
literature: Only fully automatic algorithms are 
allowed. 
 
   Fully interactive 
 Semi-automatic 
 Fully automatic 
10 Organizer 
participation 
policy* 
Participation policy for members of the 
organizers' institutes. 
 
Example 1 - Brain tumor segmentation: 
Members of the organizers' institutes may 
participate but they are not eligible for awards. 
 
Example 2 - Instrument tracking: Members of 
the organizers' institutes may not participate. 
 
Example 3 - Modality classification in biomedical 
literature: Members of the organizers' institutes 
may not participate. 
 
   Members of the organizers' institutes may 
participate but they are not eligible for 
awards and they will not be listed in the 
leaderboard. 
 Members of the organizers' institutes may 
not participate. 
11 Training data 
policy* 
 
Policy on the usage of training data. The data 
used to train algorithms may, for example, be 
restricted to the data provided by the challenge 
or to publicly available data including (open) 
pre-trained nets. 
 
Example 1 - Brain tumor segmentation: The 
challenge training data may be complemented 
by other publicly available data. 
 
   No policy as no training data is required 
 No additional data allowed 
 Publicly available data may be added 
 Private data may be added 
 Docker container 
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Example 2 - Instrument tracking: Participants 
may only use the data provided by the 
challenge for the training of their algorithms. 
 
Example 3 - Modality classification in biomedical 
literature: Participants may use their own data 
but they have to indicate and describe the 
additional data. 
 
12 Pre-evaluation 
method 
Information on the possibility to evaluate the 
algorithms before the best runs are to be 
submitted for an official challenge. 
 
Example 1 - Brain tumor segmentation: Results 
on a pre-test set 
 
Example 2 - Instrument tracking: No pre-
evaluation 
 
Example 3 - Modality classification in biomedical 
literature: No pre-evaluation 
 
   No pre-evaluation 
 Private results 
 Public leaderboard (based on pre-testset) 
 Results on validation dataset 
13 Submission 
format* 
Method that is used for result submission. 
 
Example 1 - Brain tumor segmentation: 
Participants send the algorithm output to the 
organizers via email. 
 
Example 2 - Instrument tracking: Docker 
container 
 
Example 3 - Modality classification in biomedical 
literature: Participants submit a run file that 
contains their class for each image.  
 
   Docker container 
 Cloud 
 Upload whole code  
 Upload executable 
 Send algorithm output to organizers 
 API 
 Evaluation Platform 
14 Submission 
instructions  
Instructions on how and when the participants 
should generate and prepare their submissions 
and what should be included at each stage. 
 
Example 1 - Brain tumor segmentation: On 
<date>, each team has to submit a 2-5 pages 
short paper with a description of their algorithm 
and the results on the training and test datasets 
as described in [ref]. There is no limit in the 
number of submissions. 
 
Example 2 - Instrument tracking: <link to URL> 
 
Example 3 - Modality classification in biomedical 
literature: As described in [ref]. 
 
   No instructions 
 Format of submissions 
 Timeline 
 Number of resubmissions allowed 
 Number of different submissions (different 
methods) per participant allowed 
 Missing results/cases allowance 
 Source code requirement 
15 Evaluation 
software 
 
Information on the accessibility of the 
organizers' evaluation code. 
 
Example 1 - Brain tumor segmentation: 
Software (executable and source code) publicly 
available from the moment the challenge starts 
(also after the challenge has ended): <URL> 
 
Example 2 - Instrument tracking: No evaluation 
software available (Docker concept) 
 
Example 3 - Modality classification in biomedical 
literature: Software to be used for result 
submission. Only available for registered 
participants in the ongoing challenge. 
 
 
   Not available 
 Publicly available: provide URL 
 Partially available 
 Available after registration 
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Validation objective 
16 Field(s) of 
application* 
Medical or biological application that the 
algorithm was designed for. 
 
Example 1 - Brain tumor segmentation: 
Diagnosis 
 
Example 2 - Instrument tracking: Surgery 
 
Example 3 - Modality classification in biomedical 
literature: Education 
   Training  
 Intervention planning 
 Intervention follow-up 
 Diagnosis 
 Screening 
 Assistance (e.g. tracking tasks) 
 Research (e.g. cell tracking) 
 Cross-phase  
 Education 
 Prognosis 
 Prevention 
 Medical data management 
 
17 Task 
category(ies)* 
Category(ies) of the algorithms assessed. 
 
Example 1 - Brain tumor segmentation: 
Segmentation 
 
Example 2 - Instrument tracking: Localization 
 
Example 3 - Modality classification in biomedical 
literature: Classification 
   Segmentation 
 Classification 
 Tracking 
 Retrieval 
 Detection 
 Localization 
 Registration 
 Reconstruction 
 Modeling 
 Simulation 
 Regression  
 Stitching 
 Restoration 
 Prediction 
 Denoising 
 
18 Target cohort* 
 
Description of subjects/objects from whom the 
data would be acquired in the final application. 
 
Remark: A challenge could be designed around 
the task of medical instrument tracking in robotic 
kidney surgery. While the validation (see 
parameter validation cohort) could be performed 
ex vivo in a laparoscopic training environment 
with porcine organs, the final application (i.e. 
robotic kidney surgery) would be targeted on 
real patients with certain characteristics defined 
by inclusion criteria such as restrictions 
regarding gender or age.     
 
Example 1 - Brain tumor segmentation: Patients 
diagnosed with glioblastoma that got MRI scans 
for diagnosis including T1-weighted 3D 
acquisitions, T1-weighted contrast-enhanced 
(gadolinium contrast) 3D acquisitions and T2-
weighted FLAIR 3D acquisitions. 
 
Example 2 - Instrument tracking: Patients 
undergoing laparoscopic robotic kidney surgery 
with the da Vinci Si.      
 
Example 3 - Modality classification in biomedical 
literature: Biomedical journals from PubMed 
Central (PMC), i.e. the open access literature 
indexed in Medline. 
 
   Healthy volunteers that undergo screening 
 Patients that undergo laparoscopic surgery 
 Patients that get an abdominal CT 
 Patients of a particular database  
 Patients referred for early Barrett's 
esophagus cancer without visible 
abnormalities 
 Patients attending a state-of-the-art cardiac 
MRI diagnostic centre 
 Healthy volunteers that are recruited for a 
certain study 
 Patients that get chemotherapy 
 Men with clinical suspicion of having 
prostate cancer 
 Standardized cancer cell lines (such as 
HeLa) 
 Physicians that use a da Vinci Si for 
surgical training in an ex vivo setting  
 OR team (surgeons, nurses, ...) during liver 
transplantation 
 Specific journals with an oncology focus 
(for retrieval tasks) 
19 Algorithm 
target(s)* 
Structure/subject/object/component that the 
algorithm focuses on. 
 
Example 1 - Brain tumor segmentation: 
Glioblastoma 
 
Example 2 - Instrument tracking: Robotic 
   Glioblastoma 
 Hepatocellular carcinoma (HCC) 
 Vessels 
 Liver 
 Tool tip 
 (Any) Tumor 
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instruments 
Example 3 - Modality classification in biomedical 
literature: Figures showing medical images in 
the journal 
 
 Surgeon 
 Nurse 
 Specific cell type 
 Operating room 
 Specular reflections 
 Fiber pathway 
 
20 Data origin* 
 
Region(s)/part(s) of subject(s)/object(s) from 
which the data would be acquired in the final 
application. 
 
Example 1 - Brain tumor segmentation: Brain 
 
Example 2 - Instrument tracking: Abdomen 
 
Example 3 - Modality classification in biomedical 
literature: JPEG images that appeared in the 
journal as defined by the target cohort. 
 
   Abdomen 
 Liver 
 Thorax 
 Whole body 
 Whole operating room 
 Cortical gray matter 
 Specific journal (for retrieval tasks)  
 Blood obtained from forearm 
21 Assessment 
aim(s)* 
Property(ies) of the algorithms aimed to be 
optimized.  
 
Remark: Ideally, the metrics used in the study 
assess the properties of the algorithm as 
defined by the parameter assessment aim(s). 
For example, an assessment aim could be 
targeted on the accuracy of segmentation 
algorithms. Possible metrics to assess the 
accuracy include the Dice similarity coefficient 
(DSC) and the Hausdorff distance (HD). 
 
Example 1 - Brain tumor segmentation: 
Accuracy of enhancing tumor/necrosis/edema 
segmentation 
 
Example 2 - Instrument tracking: Runtime and 
robustness 
 
Example 3 - Modality classification in biomedical 
literature: Accuracy 
 
   Accuracy 
 Robustness 
 Reliability 
 Precision 
 Sensitivity 
 Specificity 
 Consistency 
 Runtime 
 Applicability 
 Feasibility 
 Complexity 
 Usability 
 User satisfaction 
 Criteria linked to ergonomics 
 Integration in (clinical) workflow 
 Hardware requirements 
Study conditions 
22 Validation 
cohort* 
 
Subject(s)/object(s) from whom/which the data 
was acquired used to validate the algorithm.  
 
Remark: While a challenge is typically targeted 
on humans, validation may exclusively involve 
porcine models or phantoms. 
 
Example 1 - Brain tumor segmentation: Patients 
with glioblastoma (retrospective analysis) 
 
Example 2 - Instrument tracking: Ex vivo 
porcine organs in a laparoscopic training 
environment 
 
Example 3 - Modality classification in biomedical 
literature: PMC journals papers published 
between 2010 and 2015 
 
   Specific mouse model 
 Porcine model 
 Physical phantom 
 Patients under controlled conditions 
 Patients in clinical routine 
 Porcine liver (in vitro) 
 In silico data 
 Healthy volunteers 
23 Center(s)* Center(s) or institute(s) in which the data was 
acquired. 
 
Example 1 - Brain tumor segmentation: National 
Center for Tumor Diseases (NCT) Heidelberg 
 
Example 2 - Instrument tracking: As listed on 
   Centers involved in the xy study  
 University Clinic xy 
 Centers that are part of the xy consortium 
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website: <URL> 
Example 3 - Modality classification in biomedical 
literature: All centers that are mentioned in the 
articles where the JPEG images originate from 
 
24 Imaging 
modality(ies)* 
Imaging technique(s) applied for training/test 
data acquisition. 
 
Example 1 - Brain tumor segmentation: MRI 
 
Example 2 - Instrument tracking: White light 
endoscopy 
 
Example 3 - Modality classification in biomedical 
literature: Any medical imaging modality from 
the following set: <list> 
   Magnetic Resonance Imaging (MRI) 
 Computed Tomography (CT) 
 Ultrasound (US) 
 3D US 
 Intravascular US (IVUS) 
 Positron Emission Tomography (PET) 
 Light Microscopy (LM) 
 Electron Microscopy (EM) 
 X-Ray 
 Optical Coherence Tomography (OCT) 
 Endomicroscopy (w/ or w/o dye) 
 SPECT 
 Video 
 Fluoroscopy 
 Thermography 
 
25 Context 
information* 
Additional information given along with the 
images. The information may correspond 
directly to the image data (e.g. tumor 
volume), to the patient in general (e.g. gender, 
medical history) or to the acquisition process 
(e.g. medical device data during endoscopic 
surgery, calibration data for an image modality). 
 
Example 1 - Brain tumor segmentation: Clinical 
patient data: {age, gender, ...} 
 
Example 2 - Instrument tracking: API data of 
robot for each frame and CAD models of 
instruments 
 
Example 3 - Modality classification for retrieval 
tasks: None 
   No additional information 
 Genetic information 
 Age 
 Gender 
 Pathology 
 Clinical diagnoses 
 Patient number 
 Medical record 
 Weight 
 BMI 
 Race 
 Cancer (sub-)type 
 Cancer/disease stage 
 Body weight/height 
 Smoking status 
 Clinical treatment details 
 Lab data 
 Clinical history 
 OR device data 
 Free text, such as the radiology report, the 
operation report or histopathology report 
 
26 Acquisition 
device(s) 
 
Device(s) used to acquire the validation data. 
This includes details on the device(s) used to 
acquire the imaging data (parameter imaging 
modality(ies)) as well as information on 
additional devices used for validation (e.g. 
tracking system used in a surgical setting): 
 
Example 1 - Brain tumor segmentation: 3 T 
Philips Achieva scanner and GE Signa 1.5 T 
scanner 
 
Example 2 - Instrument tracking: da Vinci Si 
endoscope and NDI Aurora electromagnetic 
tracking system with standard electromagnetic 
field generator 
 
Example 3 - Modality classification in biomedical 
literature: Large variety of devices provided as a 
list 
 
   Philips Gyro Scan NT 1.5 Tesla scanner 
 GE Discovery ST multislice PET/CT 
scanner 
 G-EYE Videocolonoscope 
 MINDRAY DC-30 US scanner 
 NDI Aurora electromagnetic tracking 
system with Tabletop field generator 
 None (e.g. in case of in silico validation) 
 Unknown (e.g. in case of retrieval tasks) 
27 Acquisition 
protocol(s) 
Relevant information on the imaging process/ 
data acquisition for each acquisition device. 
 
   Dimension (e.g. 2D, 3D+t) 
 Timepoints 
 Position and orientation of patient 
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Example 1 - Brain tumor segmentation: T1-
weighted 3D acquisitions (1.0 x 1.0 x 1.0 
mm^3), T1-weighted contrast-enhanced 
(gadolinium contrast) 3D acquisitions (1.0 x 1.0 
x 1.0 mm^3), T2-weighted FLAIR 3D 
acquisitions (0.9 x 0.9 x 2.0 mm^3) 
 
Example 2 - Instrument tracking: Only left frame 
recorded with da Vinci Si system 
 
Example 3 - Modality classification in biomedical 
literature: Generally unknown 
 
 Radiation dose 
 Radiopharmaceuticals 
 Frequency of imaging 
 Resolution 
 Pixel spacing 
 MRI: T1, T2, contrast enhanced, ... 
 MRI: Repetition time (TR), echo time (TE) 
 Field of view (FOV) 
 Post-processing 
 Employed dye(s) 
 Use of filtering 
 LM: phase contrast (PhC) 
 CT: kEV  
 Microscopy: Stainings 
 Contrast agents 
 
28 Operator(s)  Characteristics of operator(s) involved in the 
data acquisition process.  
 
Example 1 - Brain tumor segmentation: N/A 
 
Example 2 - Instrument tracking: 2 male 
surgeons with more than 10 years of experience 
in laparoscopic surgery 
 
Example 3 - Modality classification in biomedical 
literature: Unknown 
   Surgeon 
 Engineer 
 Nurses 
 Robot 
 Patient (e.g. with a smartphone app used 
for melanoma detection) 
 OR 
 Technician 
 Medical trainee 
 Biologist 
 Radiologist 
 Medical Physicist 
 Radiographer 
 Sonographer 
 Unknown 
 
Reported information may be: 
 Number 
 Function 
 Names 
 Skill level (e.g. measured in the number of 
years of experience) 
 
Validation data sets 
29 Distribution of 
training and test 
cases* 
Describes how training and test data were split 
and for what reason this division was chosen. 
This should include information (1) on why a 
specific proportion of training/test data was 
chosen, (2) why a certain total amount of cases 
was chosen and (3) why certain characteristics 
were chosen for the training/test set (e.g. class 
distribution according real-world distribution vs 
equal class distribution). 
 
Example 1 - Brain tumor segmentation: 80% 
training data and 20% test data according to 
common practice in machine learning. 
 
Example 2 - Instrument tracking: All video 
sequences that are publicly available from site 
xy. Video sequences from institution x (50%) 
used for training. Video sequences from 
institution y (50%) used for testing.  
 
Example 3 - Modality classification in biomedical 
literature: 60% training data and 40% test data 
according to common practice in the domain 
[ref]. Random assignment of images to 
training/test datasets. 
 
   Not applicable as no training data is 
provided 
 Randomly distributed 
 Balanced false and negative cases 
 80% training data, 20% test data as 
recommended by [ref] 
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30 Category of 
training data 
generation 
method* 
Method for determining the desired algorithm 
output for the training data. Possible methods 
include manual image annotation, in silico 
ground truth generation and annotation by 
automatic methods, and no training data 
generated. 
 
Example 1 - Brain tumor segmentation: Hybrid: 
Initiation by algorithm and refinement/correction 
by expert physician 
 
Example 2 - Instrument tracking: Crowdsourced 
annotations 
 
Example 3 - Modality classification in biomedical 
literature: Manual annotation 
 
   Ground truth from simulation (exact) 
 Reference from algorithm 
 Reference from single human rater 
 Reference from multiple human raters 
 Hybrid: Initiation by algorithm, refinement 
by expert physician 
 Reference derived from clinical practice 
(diagnosis/disease code etc.) 
 Crowdsourced annotations 
31 Number of 
training cases* 
Number of cases that can be used for algorithm 
training and parameter optimization. A case 
encompasses all data that is processed to 
produce one result (e.g. one segmentation) as 
well as the corresponding reference result. 
 
Example 1 - Brain tumor segmentation: 400 
 
Example 2 - Instrument tracking: 5 video 
sequences, each containing 100 annotated 
frames 
 
Example 3 - Modality classification in biomedical 
literature: 6,000 
 
   No training data provided 
 100 images 
 100 raw endoscopic video sequences with 
a total of 1,000 fully annotated frames 
 
 
32 Characteristics 
of training 
cases* 
Additional information on the training cases 
describing their nature, such as the level of 
detail of the annotations (e.g. fully vs weakly 
annotated). 
 
Example 1 - Brain tumor segmentation: Pixel-
level segmentation of the structures of interest 
and additional clinical information as described 
in context information. 
 
Example 2 - Instrument tracking: Full 
segmentation of 100 frames (equally distributed) 
in each video sequence. No segmentation of the 
instruments in the remaining frames, but API 
information on instrument poses available for all 
frames. 
 
Example 3 - Modality classification in biomedical 
literature: Full annotation - modality/image type 
per image 
 
   No training data provided 
 Full annotation (pixel level) 
 Weak annotation (image level): tumor 
volume, disease stage 
 Mixed annotation: 1,000 fully annotated 
images, 100 weakly annotated images  
 100 endoscopic video images with 10 fully 
annotated training images 
33 Annotation 
policy for 
training cases* 
Instructions given to the annotators prior to 
training case annotation. This may include 
description of a training phase with the 
software.  
 
Example 1 - Brain tumor segmentation: The 
annotator was instructed to segment the edema 
using the T2 and FLAIR images. The enhancing 
tumor was subsequently to be segmented on 
the T1 contrast-enhanced modality. Finally, the 
necrotic core was to be outlined using the T1 
and contrast-enhanced T1 image. The 
annotations were to be performed in axial slices. 
The undergraduate student received training on 
5 cases (by the radiologist) to extract the weak 
labels (see parameter: context information). 
   Challenge-specific detailed instructions – 
e.g. should an annotation be performed 
along a tumor boundary or including a 
safety zone? Is it allowed to guess a 
boundary if not clearly visible?  
 URL to annotation instructions 
 What tissue would you resect?  
 Where would you take a (small) biopsy? 
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Example 2 - Instrument tracking: <URL to 
annotation instructions> 
 
Example 3 - Modality classification in biomedical 
literature: Instruction to label each cropped 
image with the modality that has (presumably) 
been used to acquire the image shown in the 
figure. List of potential labels: <list>. No further 
instructions, no training. 
 
34 Annotator(s) of 
training cases* 
Details on the subject(s)/algorithm(s) who/which 
annotated the training data.  
 
Example 1 - Brain tumor segmentation: Weak 
annotation (parameter context 
information) extracted from medical reports by 
undergraduate medical student; full image 
annotation performed by radiologist. 
 
Example 2 - Instrument tracking: Crowdsourcing 
of image annotations on the platform Amazon 
Mechanical Turk according to the method in 
paper [ref]. Pose data (parameter context 
information) is automatically acquired by the 
robot 
 
Example 3 - Modality classification in biomedical 
literature: Three PhD students 
 
   No training data provided 
 Surgeon who has done >100 cases of a 
specific type of surgery 
 Undergraduate physician (third year)  
 Engineer who developed the software 
 Physician with no prior experience in usage 
of the software 
 Crowd 
 Algorithm xy 
 
 
 
 
35 Annotation 
aggregation 
method(s) for 
training cases* 
Method(s) used to merge multiple annotations 
for one case. 
 
Example 1 - Brain tumor segmentation: (only 
one observer) 
 
Example 2 - Instrument tracking: According to 
[ref] 
 
Example 3 - Modality classification in biomedical 
literature: Majority vote 
   No aggregation 
 Simultaneous Truth and Performance 
Level Estimation (STAPLE) 
 Majority vote 
 An additional annotator resolves conflicts 
 Average 
 Selective and Iterative Method for 
Performance Level Estimation (SIMPLE) 
 Level-set based approach maximizing the 
a posteriori probability (LSML) 
 Strict combination (positive if and only if all 
annotators agree) 
 No training data is required 
 
36 Category of 
reference 
generation 
method* 
Method for determining the reference (i.e. the 
desired algorithm result, also referred to as gold 
standard) which is used for assessing 
the participants' algorithms. Possible methods 
include manual image annotation, in silico 
ground truth generation and annotation by 
automatic methods. 
 
Example 1 - Brain tumor segmentation: Manual 
annotation 
 
Example 2 - Instrument tracking: Crowdsourced 
annotations 
 
Example 3 - Modality classification in biomedical 
literature: Manual annotation by multiple 
observers 
 
   Ground truth from simulation (exact) 
 Reference from algorithm 
 Reference from single human rater 
 Reference from multiple human raters 
 Acquired through previously validated 
methods according to [ref] 
 Reference derived from clinical practice 
(diagnosis/disease code etc.) 
 Crowdsourced annotations 
 Hybrid methods (e.g. initiation by algorithm, 
refinement by expert physician) 
37 Number of test 
cases* 
Number of cases used to assess the 
performance of an algorithm. A case 
encompasses all data that is processed to 
produce one result as well as the corresponding 
reference result (typically not provided to the 
participants). 
 
   100 images  
 100 raw endoscopic video sequences with 
a total of 1,000 fully annotated frames 
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Example 1 - Brain tumor segmentation: 100 
 
Example 2 - Instrument tracking: 5 video 
sequences, each containing 100 annotated 
frames. 
 
Example 3 - Modality classification in biomedical 
literature: 4,000 
 
38 Characteristics 
of test cases* 
Additional information on the test cases 
describing their nature, such as the level of 
detail of the annotations (e.g. fully vs weakly 
annotated). 
 
Example 1 - Brain tumor segmentation: Pixel-
level segmentation of the structures of interest 
and additional clinical information as described 
in context information 
 
Example 2 - Instrument tracking: Full 
segmentation of 100 frames (equally distributed) 
in each video sequence. No segmentation of the 
instruments in the remaining frames, but API 
information on instrument poses available for all 
frames 
 
Example 3 - Modality classification in biomedical 
literature: Full annotation - modality/image type 
per image 
 
   Full annotation (pixel level) 
 Weak annotation (image level): tumor 
volume, disease stage 
 Mixed annotation: 1,000 fully annotated 
images, 100 weakly annotated images  
 100 endoscopic video images with 10 fully 
annotated test images 
39 Annotation 
policy for test 
cases* 
Instructions given to the annotators prior to test 
case annotation. This may include description of 
a training phase with the software.  
 
Example 1 - Brain tumor segmentation: The 
annotator was instructed to segment the edema 
using the T2 and FLAIR images. The enhancing 
tumor was subsequently to be segmented on 
the T1 contrast-enhanced modality. Finally, the 
necrotic core was to be outlined using the T1 
and contrast-enhanced T1 image. The 
annotations were to be performed in axial slices. 
The undergraduate student had received 
training on extracting the weak labels when 
annotating the training images. 
 
Example 2 - Instrument tracking: <URL to 
annotation instructions> 
 
Example 3 - Modality classification in biomedical 
literature: Instruction to label each cropped 
image with the modality that has (presumably) 
been used to acquire the image shown in the 
figure. List of potential labels: {...}. After two 
observers have annotated the images 
independently, the cases where the annotators 
disagreed will be automatically retrieved. These 
should be shown to the third observer for 
resolving conflicts. Training on the training 
cases. 
 
   Challenge-specific detailed instructions – 
e.g. should an annotation be performed 
along a tumor boundary or including a 
safety zone? Is it allowed to guess a 
boundary if not clearly visible? 
 URL to annotation instructions 
 What tissue would you resect?  
 Where would you take a (small) biopsy? 
40 Annotator(s) of 
test cases* 
Details on the subject(s)/algorithm(s) who/which 
annotated the test data.  
 
Example 1 - Brain tumor segmentation: 
Radiologist with 5 years of experience 
 
Example 2 - Instrument tracking: Crowdsourcing 
on the platform Amazon Mechanical Turk 
   Surgeon who has done >100 cases of a 
specific type of surgery 
 Undergraduate physician (third year)  
 Engineer who developed the software 
 Physician with no prior experience in usage 
of the software 
 Crowd 
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according to the method [ref] 
 
Example 3 - Modality classification in biomedical 
literature: Two PhD students and a radiologist 
 
 Algorithm xy 
41 Annotation 
aggregation 
method(s) for 
test cases* 
Method(s) used to merge multiple annotations 
for one case (if any). 
 
Example 1 - Brain tumor segmentation: No 
merging  
 
Example 2 - Instrument tracking: According to 
[ref] 
 
Example 3 - Modality classification in biomedical 
literature: Expert resolves conflicts 
 
   No aggregation (ranking provided for each 
annotator) 
 STAPLE 
 Majority vote 
 An additional annotator resolves conflicts 
 Average 
 SIMPLE 
 LSML 
 Strict combination (positive if and only if all 
annotators agree) 
42 Data pre-
processing 
method(s) 
Methods used for pre-processing the raw data 
before it is provided to the participants. 
 
Example 1 - Brain tumor segmentation: 
Registration of different contrasts using 
algorithm x and denoising using algorithm y. 
Both performed in framework z. Resampling to 
common coordinate system with spatial 
resolution 1x1x1mm^3; skull stripping according 
to [ref], bias field correction according to [ref]. 
 
Example 2 - Instrument tracking: Irrelevant 
scene removal using algorithm xy [ref] with 
parameters z. 
 
Example 3 - Modality classification in biomedical 
literature: Cropping to figures; if compound 
figures are included, then these are separated 
manually into the subfigures using the 
software xy. 
   No pre-processing steps 
 Registration with a particular method 
 Segmentation with a particular method 
 Resampling of raw data 
 Re-orientation 
 Normalization 
 Data cleaning 
 Instance selection 
 Feature extraction 
 Feature selection 
 Video anonymization 
 Bias correction 
 Intensity standardization 
 White balancing 
 Smoothing 
 Skull stripping 
 Histogram Matching 
 Background subtraction 
 Uneven background intensity correction 
 Image enhancement (contrast/brightness 
change, histogram equalization)  
 Data format conversion (DICOM to NIFTI) 
 Journals: cropping, grey level reduction  
 
43 Potential 
sources of 
reference 
errors  
Most relevant possible error sources related to 
the estimation of the reference. This may 
include errors related to the image acquisition 
method, user errors and errors resulting from 
the pre-processing method applied. It may be 
quantified by inter- and intra-observer variability, 
for example. This information must be provided 
for the test cases and may be provided for the 
training cases. 
 
Example 1 - Brain tumor segmentation: Tissue 
classes (tumor necrosis, enhancing tumor and 
edema) difficult to distinguish. Previous studies 
suggest inter-rater disagreement of xy [ref]. 
 
Example 2 - Instrument tracking: The provided 
API robot pose data has an estimated accuracy 
of x according to additional experiments 
performed with the calibration phantom 
described in [ref]. The accuracy of 
crowdsourced segmentations of medical  
instruments with the applied method has been 
estimated to be around z [ref]. 
 
Example 3 - Modality classification in biomedical 
literature: Previous experiments [ref] suggest 
 Sources of error: 
 Partial volume effects 
 Errors resulting from surface generation 
 User errors 
 Organ deformation 
 Distortion of electromagnetic field 
 Noise 
 Imaging system aberrations (deteriorated 
point spread function resulting in blurring) 
 Imaging system artifacts (dust, motion, 
spikes, etc.) 
 Interlacing 
 
Quantification: 
 Inter-/ intra-observer variability 
 Confidence intervals 
 Kappa statistics 
 Correlation coefficients 
 Signal-to-noise ratio 
 Resolution 
 Bland-Altman Plots 
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that the main source of error is related to 
ambiguity in the images, as there is an 
extremely large variability and sometimes the 
defined image types are hard to fit into the 
existing hierarchy of a small number of image 
types; other mistakes can be linked to 
annotating quickly and not looking at sometimes 
fine differences. Inter-observer variability in a 
separate experiment was x%. 
 
Assessment method 
44 Metric(s)* Function(s) to assess a property of an 
algorithm. These functions should reflect the 
validation objective (see parameter assessment 
aim(s)).  
 
Example 1 - Brain tumor segmentation: 95% HD 
and precision applied separately to necrosis, 
enhancing tumor and edema. 
 
Example 2 - Instrument tracking: Runtime per 
frame on an xy device; Percentage of frames 
with DSC below threshold t. 
 
Example 3 - Modality classification in biomedical 
literature: Accuracy 
   Hausdorff distance (HD) 
 Dice similarity coefficient (DSC) 
 Jaccard index 
 Computation time 
 Recall 
 Precision 
 Area under curve (AUC) 
 Root mean square error (RMSE) 
 Absolute volume difference 
 True positive rate 
 Computational complexity 
 Average symmetric surface distance 
(ASSD) 
 F1-Score 
 Specificity 
 Intraclass correlation coefficient 
 Concordance index 
 MAP 
45 Justification of 
metric(s)* 
Justification why the metric(s) was/were chosen, 
preferably with reference to the clinical 
application. 
 
Example 1 - Brain tumor segmentation: 95% 
Hausdorff Distance as opposed to standard HD: 
Try to avoid that outliers have too much weight. 
All other metrics are commonly used in 
segmentation assessment (cf. ref. xy).  
 
Example 2 - Instrument tracking: Thresholded 
DSC according to best practice 
recommendations [ref]. Computation time as 
clinical application requires video rate 
performance. 
 
Example 3 - Modality classification in biomedical 
literature: Accuracy is the most common method 
as easy to interpret; geometric mean assures 
that all classes are well classified and not only 
the majority classes.  
 
   According to best practice 
recommendations [ref] 
 According to paper [ref] 
46 Rank 
computation 
method* 
Method used to compute a rank for all 
participants based on the generated results on 
the test data. It may include methods for 
aggregating over all test cases and/or for 
determining a final rank from multiple single 
metric-based ranks. It also includes the ranking 
order for tied positions. 
 
Example 1 - Brain tumor segmentation: For 
each participant pi and each test case cj: 
Compute the metric values for the 95% 
Hausdorff distance and precision. For each 
participant pi and each test case cj, determine 
the rank corresponding to both metrics (i.e. 
R(precision, pi, cj): descending order for 
precision, R(HD, pi, cj) ascending for 95% HD). 
 Example 1: 
0. Initialization: For each participant pi and 
each test case cj: compute metric values 
M1(pi,cj) and M2(pi,cj) for metrics M1 and 
M2. 
1. Metric-based aggregation: For each 
participant pi compute the median over all 
cases cj for each metric M1(pi) and M2(pi). 
2. For each participant pi, compute the sum 
over the two metrics as M1(pi) + M2(pi). 
3. Build rank for each participant by sorting 
the values M1(pi) + M2(pi) for each 
participant. 
 
Example 2: 
0. Initialization: For each participant pi and 
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For each participant pi and each test case cj, 
compute the average rank R(pi, cj) over both 
metric ranks. Finally, compute the average over 
all case-specific ranks to get one final rank for 
each participant pi.  
 
Example 2 - Instrument tracking: For each 
participant pi compute the average metric value 
for the thresholded DSC. Build the rank for each 
participant by sorting the accumulated metric 
values. In case of tied positions, perform the 
ranking according to computation times. 
 
Example 3 - Modality classification for retrieval 
tasks: Ranking performed according to [ref]. 
 
each test case cj: compute metric values 
M1(pi,cj), M2(pi,cj) and M3(pi,cj) for metrics 
M1-M3. 
1. Case-based aggregration: For each 
partipant pi and each case cj, determine 
the performance score sj on case cj: sij := 
1/3 (M1(pi,cj) + M2(pi,cj) + M3(pi,cj)). 
2. For each partipant pi and each case cj, 
determine the rank R(pi,cj) for case cj 
according to score sj. 
3. Compute the average over all case-specific 
ranks for each participant pi si := 
1/N*Sum_j (R(pi,cj)) to obtain the final 
rank. 
47 Interaction level 
handling* 
Method(s) used to handle any diversity in the 
level of user interaction when generating the 
performance ranking. 
 
Example 1 - Brain tumor segmentation: 
Weighting function (automatic methods are 
ranked higher) 
 
Example 2 - Instrument tracking: Only automatic 
algorithms are allowed. 
 
Example 3 - Modality classification in biomedical 
literature: Only automatic methods are allowed. 
 
   Indication in ranking 
 Separate ranking for fully-automatic 
methods 
 Only automatic methods allowed 
48 Missing data 
handling*  
Methods used to manage submissions with 
missing results on test cases. 
 
Example 1 - Brain tumor segmentation: In case 
of missing data for participant pi and case cj, the 
case-based ranks for all metrics m R(m, pi, cj) 
are set to the maximum. 
 
Example 2 - Instrument tracking: Only complete 
submissions are evaluated. 
 
Example 3 - Modality classification in biomedical 
literature: Missing results are considered to be 
incorrectly classified 
 
   Missing data not allowed (incomplete 
submissions not evaluated) 
 Missing data ignored 
 Missing data handled as in [ref] 
49 Uncertainty 
handling* 
Method(s) used to make uncertainties in ranking 
explicit.  
 
Example 1 - Brain tumor segmentation: Test the 
sensitivity of the ranking with bootstrapping 
according to [ref]. 
 
Example 2 - Instrument tracking: Test the 
sensitivity of a ranking by leaving out different 
amounts of test data as described in [ref]. 
 
Example 3 - Modality classification in biomedical 
literature: None 
 
  Test sensitivity of the ranking by  
 Leaving out test data 
 Bootstrapping approaches 
 Changes in rank computation details 
 Changes in reference annotation 
50 Statistical 
test(s)* 
Statistical test(s) used to compare the results of 
challenge participants. 
 
Example 1 - Brain tumor segmentation: T-test 
used to test the stability of the first three ranks 
as described in [ref]. 
 
Example 2 - Instrument tracking: U-test used to 
test statistically significant differences between 
 Quantities on which the hypothesis is taken: 
 Stability of the ranking 
 See whether the best results have 
statistically significant differences 
 
Tests: 
 Wilcoxon-Mann-Whitney test 
 t-test (paired, unpaired, one-sided, two-
sided) 
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the participants as described in [ref]. 
Example 3 - Modality classification in biomedical 
literature: No statistical tests. 
 
 Saphiro-Wilk test 
Challenge outcome 
51 Information on 
participants 
 
 
Information on participating teams including 
affiliation and specifics of competing algorithm, 
preferably with reference to a document. 
 
 
 Should include:  
 Acronym 
 Affiliation 
 Contact person 
 Team members 
 Method description including parameter 
instantiation 
 Submission/attempt number 
 Relevant reference publication 
 
52 Results 
 
Values of all metrics and rankings including the 
number of submissions for each participant. 
 
Example 1 - Brain tumor segmentation: Not yet 
available 
 
Example 2 - Instrument tracking: Matrix with 
colums = participants; rows = (case j, metric k); 
in addition two rankings for the two metrics and 
the final ranking. 
 
Example 3 - Modality classification in biomedical 
literature: Two rankings corresponding to the 
two metrics and the associated aggregated 
values. 
 
   Not yet available 
 Link to URL 
 Matrix with results for each participant, 
each metric and each test case plus 
ranking 
53 Publication 
 
Evaluating and summarizing information about 
the challenge or the workshop published in a 
scientific journal or similar literature, preferably 
with DOI. 
 
Example 1 - Brain tumor segmentation: IEEE 
Transactions on Medical Imaging: <link to pdf> 
 
Example 2 - Instrument tracking: arXiv 
publication: <URL> 
 
Example 3 - Modality classification in biomedical 
literature: Publication in CEUR: <DOI> 
 
   No publication 
 DOI 
 Link to document 
 Full citation 
 arXiv ID 
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Supplement 2 
 
Questionnaire: Towards next-generation biomedical challenges 
The questions of the online questionnaire were related to the following categories: 
 
General information 
 What is your position? 
 Which country do you live in? 
 What is your primary background? 
 
Background with respect to challenge participation 
 Have you taken part in a challenge to date? If so, how many challenges? 
 How much effort do you put into a challenge participation? 
 Before the challenge: What was your motivation to participate in a challenge? 
 During the challenge: What did you struggle the most with before submitting your results? 
 After submitting your results: Did you encounter problems interpreting your challenge rank? 
 Have you ever registered as a participant of a challenge for which you did not submit results?  
If so, how many times? What were the main reasons for not submitting results? 
 
Background with respect to challenge organization 
 Have you ever taken part in the organization of a challenge? If so, how many challenges? 
 Have you ever participated in your own challenge? 
 In percent, please estimate the time the challenge organizers (as a group) put in the 
i. design of the challenge 
ii. preparation of the challenge 
iii. processing of submissions 
iv. on-site execution of the challenge 
 Please estimate how many hours the organizing team spent in total on preparing and  
executing the challenge. 
 Did you struggle with any of the following problems during designing your challenge? 
i. Choosing the metrics 
ii. Finding data sets 
iii. Creating the reference data 
iv. Deciding on how to create the challenge ranking 
v. None of them 
vi. Other 
 Did you encounter problems during preparing your challenge? Which ones? 
 Did you encounter problems during the processing of the submissions of your challenge? 
Which ones? 
 Did you encounter problems during the on-site execution of your challenge (if any)? Which 
ones? 
 Can you think of aspects that you would like to improve in the future? 
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Issues related to challenge design and organization 
 What do you consider issues related to the data of biomedical challenges? 
 What do you consider issues related to the annotation (reference data) of biomedical 
challenges? 
 What do you consider issues related to the evaluation of biomedical challenges? 
 What do you consider issues related to the documentation of biomedical challenges? 
 
General view on challenges 
 Should challenge organizers provide pre-evaluation results? 
 Should challenge organizers (and group members) be allowed to participate in their own 
challenge? 
 Please explain under which conditions challenge organizers (and group members) should be 
allowed to participate in their own challenge. 
 How serious do you rate the fact that algorithms can be tuned to the challenge data? 
 Do you generally think that challenge rankings reflect algorithm performances well? 
 Do you think the design of current biomedical challenges should be improved in general? 
 
Open issues and recommendations 
 What recommendations do you have for the improvement of biomedical challenges? 
 What are open research issues with respect to biomedical challenge design? 
 Would you appreciate best practice guidelines for biomedical challenges? 
 Should challenges organized in the scope of big conferences (e.g. MICCAI) undergo more 
quality control? 
 What actions could the research community (i.e. MICCAI society) undertake to improve 
challenge quality in general? 
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Supplement 3 
 
Results of Questionnaire: Towards next-generation biomedical challenges 
For the following analysis, only complete questionnaires (n = 117) and questionnaires with > 50% 
answers  (n = 12) were considered. The majority of the participants were professors (30%), PhD 
students (23%) and postdoctoral researchers (14%) and had a background in engineering, maths, 
physics or computing (94%). 31% of the participants had already organized a challenge and 63% 
had taken part in at least one challenge. 92% of all participants agreed that biomedical challenge 
design should be generally improved. The following problems were identified for the categories 
data, annotation, evaluation and documentation. For all four categories, we report the most 
commonly reported problems ordered by frequency of reporting. 
 
Data 
Representativeness (33%): Most concerns were related to the representativeness of the data. 
Criticism was targeted mainly at the representativeness of the training and test sets, balance of the 
data (e.g. between positives and negatives), selection bias, realism of the data (e.g. with respect to 
noise and artefacts) and the typically small number of centers/vendors/devices involved. In fact, 
our analysis revealed that the median number of institutes involved in a challenge was 1 (IQR: (1, 
1)) and only 17% of all tasks conducted up to 2016 were based on multi-center data. 
One critical consequence of the generally small data sets is that challenge participants tend to 
complement available training data with their own data sets which makes it impossible to 
distinguish the effect of an algorithm from the effect of the training data. 
 
Data acquisition (17%): Participants agreed that the data acquisition itself is one of the main 
barriers for challenge organizers, especially due to legal barriers and high costs. In fact, 22% of 
challenge organizers encountered problems acquiring the data sets for their challenge. One of the 
main reasons for participation in a challenge was the access to validation data (30% of challenge 
participants). 
 
Further problems mentioned include 
 Heterogeneity (8%), e.g. due to the lack of acquisition standards 
 Infrastructure issues (8%), mainly due to inconsistencies in formats and the lack data 
management and exploration tools 
 Accessibility of the data (8%), mainly after the challenge 
 Lack of documentation (8%), especially about the image acquisition process 
 Data quality (6%), in general and 
 Overfitting/Cheating/Tuning (4%). 
 
Annotation 
Quality of reference data (33%): Major concerns were related to errors in the reference data. The 
annotations were regarded as subjective and/or biased, e.g. because only single observers 
annotated the data in many cases or automatic tools were used either for the annotations 
themselves or for the initialization in semi-automatic tools. The lack of quality control in this step 
was regarded particularly critically for many challenges. 
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Method for reference generation (16%): A related issue is the method chosen for reference 
annotation. For example, studies have shown (e.g. [Lampert et al. 2016]) that reference 
annotations may vary significantly even across medical experts. This issue can potentially be 
compensated to some extent by merging reference annotations from multiple experts but this was 
only done (reported) in 73% of all tasks. It should also be noted that 27% of all challenge 
organizers encountered problems when generating the reference data for their challenge. 
 
Transparency (15%): Lack of transparency was another major issue raised in the context of data 
annotation. In particular, it was requested to make raw annotations available, report on inter- and 
intra-observer variability and document how the final reference annotation was generated. 
 
Resources (14%): Another issue raised were the resources required for providing high-quality 
reference data. The annotation was not only considered particularly challenging but also logistically 
hard due to improper tools. 
 
Lack of standards (10%): The lack of guidelines for annotating and merging annotations was 
heavily criticized. Similarly, the lack of standard data formats was regarded critical. 
 
Evaluation 
Choice of metric (20%): The metrics applied in current challenges were generally criticized. For 
example, it was stated that runtime/computational complexity are rarely considered. The metrics 
are also often not well linked to the clinical context. Finally, optimal metric aggregation is a major 
issue to be addressed, especially in the case of missing data. On the other hand, participants 
agreed that finding the right metric(s) for a given task is highly challenging. In fact, 23% of all 
challenge organizers struggled with the choice of metric(s). 
 
Lack of standards (19%): A major point of criticism was related to the lack of standards with 
respect to metrics and evaluation frameworks. For example, even the presumably same metrics 
are sometimes named or applied differently. 
 
Transparency (12%): Missing documentation with respect to the evaluation process was criticized. 
Concerns were raised regarding the fact that the evaluation criteria are not transparent before the 
submission of data, potentially allowing organizers to influence the final ranking. 
 
Further difficulties raised include 
 Lack of infrastructure/tools (7%) such as public tools for evaluation 
 Method for determining ranking (7%), for instance, in the case of missing values 
 Lack of quality control (7%), e.g. related to metric implementation 
 Too much focus on ranking (5%), especially when considering the sensitivity of the ranks 
 Lack of uncertainty handling (4%), especially when considering inter-observer variability as 
well as 
 Lifetime and dynamics (3%) of challenges. 
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Documentation 
Completeness and transparency (47%): Participants agreed that the documentation should be as 
comprehensive as possible, which is currently not the case. This holds true not only for the 
reporting of challenge design and results but also for the methods themselves. For example, a 
challenge ranking should reflect the quality of a method in the context of a given task. 
Unfortunately, however, method performance may depend crucially on its parameters. Given that 
only 4% of challenge participants stated that they typically apply their algorithm “as is” to new 
challenge data, and more than 80% of participants tune their methods to a given task, it comes at a 
surprise that almost no attention is given to the parameters applied by the algorithms assessed. 
 
Publication of results (13%): Issues with respect to the publication of results further include the 
delay between submission deadline and paper publication as well as discrepancies between the 
challenge website and the corresponding publication. 
 
Lifetime and dynamics (10%): Another problem raised was the typically dynamically changing 
content of challenge websites, which makes proper referencing hard. An open research question is 
further the optimal lifetime of a challenge considering problems with overfitting, for example. 
 
Further problems related to the documentation were 
 Lack of open source code (9%) corresponding to participating algorithms and the evaluation 
 Lack of standards for structured reporting (7%), such as common ontologies 
 Accessibility of information (5%) especially after the challenge as well as the 
 Lack of acknowledgement/citation of all people involved (3%). 
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